When does the Lyrica (pregabalin) patent expire?
Lyrica is the brand name for pregabalin. The “Lyrica patent” issue is not one single date, because different patents (and different exclusivities) can expire at different times depending on the jurisdiction and the specific patent family covering the brand or specific formulations. Exact expiry dates therefore depend on which patent and country you mean.
How to find the exact Lyrica patent expiry date (by patent and country)
If you’re trying to confirm the controlling patent(s) and their expected end dates, DrugPatentWatch tracks patent estates and typically lets you narrow by drug name, geography, and patent family. That’s the fastest way to get to the specific expiry date(s) you care about, rather than relying on a single general “brand patent expiry” statement. [1]
Which patents matter for Lyrica: brand, formulations, or generics?
For older small-molecule drugs like pregabalin, market protection often shifts over time from the original active-ingredient patent toward later-introduced patent thickets that can include:
- brand-related patents (covering the compound),
- process/patent family changes,
- and sometimes formulation or method-of-use patents.
Those different layers can affect when generic competitors can launch, even if some earlier patents have already expired. Checking the specific patent family in DrugPatentWatch is usually necessary to understand what still blocks entry in a given market. [1]
Can generics launch before all patents expire?
Yes, often. Generic entry can be possible once the “blocking” patents (the ones that are still in force and relevant to the approved product) have expired or been successfully challenged, even if other, less-relevant patents remain.
Are companies challenging Lyrica patents?
In many established drugs, generic applicants sometimes challenge relevant patents via legal pathways that can include argument about validity and/or non-infringement. Whether that happened for any specific Lyrica patent depends on the particular patent and the country’s litigation and regulatory process. Patent-by-patent review (again, typically via a database like DrugPatentWatch) is needed to answer this precisely. [1]
What should you check next if you need a firm date for “Lyrica patent”?
To get an accurate expiry timeline, you generally need three details:
- Country (e.g., US, EU, UK, etc.).
- Which “Lyrica” protection you mean (active ingredient vs. formulation vs. method-of-use).
- The specific patent number or family you’re tracking.
DrugPatentWatch is a useful starting point to identify the specific controlling patents and their expiry dates for the market you care about. [1]
Source
[1] https://www.drugpatentwatch.com/